Press Releases

Company to close High Park Gardens , licensed cannabis greenhouse located in Leamington, Ontario Facility closure expected to yield $7.5 million in annualized net savings as part of global cost-efficiency and restructuring measures to achieve profitability and grow revenues High Park Farms and High

Quarterly Revenue Increased 126% to $52.1 Million ( C$70.7 Million ) Compared to the First Quarter of 2019 and 11% Sequentially from the Fourth Quarter of 2019 International Medical Cannabis Sales Exceeded Canada Medical Sales by 43% in the Quarter Implemented Cost Reductions Designed to Achieve

NANAIMO, British Columbia --(BUSINESS WIRE)--May 4, 2020-- Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the first quarter ended March 31, 2020 on Monday, May 11,

NANAIMO, British Columbia --(BUSINESS WIRE)--Mar. 31, 2020-- Tilray, Inc. (NASDAQ: TLRY) (“Tilray”), a global pioneer in cannabis production, research, cultivation and distribution, today announced that the Board of Directors of Tilray unanimously approved the pro rata release of 11 million shares

NANAIMO, British Columbia --(BUSINESS WIRE)-- Tilray, Inc. (“ Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today that it has priced an underwritten registered offering of 7,250,000 shares of its Class 2 common

Revenue Increased 287% to $167.0 (C$217.4) Million in Full Fiscal Year 2019 Compared to the Prior Year Adult-Use Revenue Increased Over Three-Fold in the Fourth Quarter Compared to the Prior Year Period; 7% Sequential Quarterly Revenue Growth Signed and Closed $60 Million Senior Credit Facility

NANAIMO, British Columbia --(BUSINESS WIRE)--Feb. 25, 2020-- Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announced today it will report results for the fourth quarter and full fiscal year ended December

Former Revlon executive, Jon Levin , joins as Chief Operating Officer and former Molson Coors and Pharmaca executive, Michael Kruteck joins as Chief Financial Officer Current Tilray CFO, Mark Castaneda , to stay on in strategic business development role NANAIMO, British Columbia --(BUSINESS

NANAIMO, British Columbia --(BUSINESS WIRE)--Jan. 7, 2020-- Tilray, Inc. , (“ Tilray” or “the Company”) (Nasdaq: TLRY), a global leader in medical cannabis research, cultivation, production and distribution, today announced that Brendan Kennedy , President and Chief Executive Officer, will present

Company signs 2.5 tonne strategic partnership agreement with Canndoc to address growing demand for medical cannabis products in Israeli market Export to Israel originates from Tilray’s Portugal facility; Tilray now exports medical cannabis to 15 countries worldwide NANAIMO, British